Stockholders approve merger agreement with Eli Lilly and Company

AtaiBeckley Inc. held a virtual special meeting of its stockholders on September 8, 2026, to vote on the proposed merger with Eli Lilly and Company. As of the record date, August 7, 2026, there were 370,864,669 shares of common stock outstanding and eligible to vote.

A quorum was established at the meeting with 243,351,557 shares of common stock present, representing approximately 65.6% of the outstanding shares. Stockholders overwhelmingly approved the merger proposal, with 237,762,253 votes in favor, 5,033,755 votes against, and 555,549 abstentions.

The proposal to adjourn the meeting, if necessary to solicit additional proxies, was also approved with 229,411,340 votes for, 12,814,164 against, and 1,126,053 abstentions. However, this proposal was not acted upon since the merger proposal had already passed.

AtaiBeckley anticipates the merger will be completed on September 11, 2026, assuming all remaining conditions are satisfied or waived. The definitive proxy statement detailing the merger agreement was filed with the SEC on August 10, 2026, and mailed to stockholders on the same day.